Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
It is the aim of this clinical study to evaluate the skeletal-related event rate under
therapy with zoledronic acid in patients with renal cell cancer having at least one
cancer-related bone lesion.